-
2022 ASCO Insights ADC on the Frontiers of Lung Cancer
Time of Update: 2022-09-07
Antibody drug conjugates (ADCs) are a class of targeted biological agents that conjugate monoclonal antibodies to cytotoxic drugs through specific connectors, which have both antibody drug targeting a
-
Can abstaining from alcohol reduce the risk of liver cancer? High score study
Time of Update: 2022-09-07
This cohort study showed that increased drinkers had a higher risk of alcohol-related and all cancers compared to those who maintained drinking levels, while those who reduced their drinkers had a lower risk.
-
[CLEAR Collier 1 case per day] Alcoholic cirrhosis with localized hepatic fat infiltration lesions misdiagnosed as liver cancer
Time of Update: 2022-09-07
8cm of hepatic caudate lobe;d: Enhanced CT before treatment shows low density shadow without significant strengthening;e: 3 weeks after hormonal therapy, CT flat scan before treatment of low-density shadow disappearance;f: The patient's re-examination of CT after one month of discharge showed that the low-density shadow completely disappeared Case Description:The patient, male, 51 years old, was admitted to the hospital for 5 years due to repeated poor admission and fatigue.
-
Half of the world's esophageal cancer is in China, how to regulate the prevention and treatment?
Time of Update: 2022-09-07
Esophageal cancer has familial aggregation, and the risk of esophageal squamous cell carcinoma in individuals with both parents suffering from esophageal cancer is about 8 times that of the general population .
-
【PHILIPS once a day】1 case of pleural epithelioid hemangioendothelioma
Time of Update: 2022-09-07
The patient is a 51-year-old female . Acupuncture-like pain in the left chest with no obvious cause for 1 year, with intermittent attacks . The CT examination results are shown in Figures 1 to 3. The
-
What is the risk of prostate cancer after benign prostatic hyperplasia? Need additional monitoring? This 20-year tracking and analysis data of more than 60,000 people was revealed!
Time of Update: 2022-09-07
A total of 6685 men underwent follow-up histological examinations after the initial benign TURP.
A total of 6685 men underwent follow-up histological examinations after the initial benign TURP.
A total of 6685 men underwent follow-up histological examinations after the initial benign TURP.
-
Efficacy of adjuvant therapy and neoadjuvant therapy plus immunotherapy in resectable non-small cell lung cancer
Time of Update: 2022-09-07
For therapeutic strategies for non-small cell lung cancer (NSCLC), is neoadjuvant chemo/immunotherapy superior to adjuvant chemo/immunotherapy with adjuvant chemotherapy? This is an interesting and pr
-
【Cell Sub-issue】Professor Zhu Di of Fudan University and Professor Xu Jianmin of Zhongshan Hospital Affiliated to Reveal the Mechanism of Colon Cancer Liver Metastasis
Time of Update: 2022-09-07
Recommended · Live/EventAugust 31st 14:00-17:30 GuangzhouThe 2nd Clinical Application Salon of New Diagnostic TechnologyScan the code to participate for freeSeptember 15-16 09:00-17:30 ChongqingThe First Southwest Single Cell Omics Technology Application ForumScan the code to participate for freeThis article is original from Translational Medicine Network, please indicate the source for reprinting Author: TMZHIIntroduction: Tumor metastasis is a malignant process influenced by many factors, among which the influence of tumor microenvironment (TME) is huge .
-
"Fei" long vision - big coffee visit wang shuo, Jiang Shusuan, Professor Wang Yong: with ADT treatment as a companion, continue to write the life of prostate cancer patients
Time of Update: 2022-09-07
Editor's NoteNew drugs are booming, and various treatments are emerging in an endless stream, but prostate cancer has come all the way without androgen deprivation therapy (ADT), which is the basic tr
-
Professor Su Chunxia: The pattern is open, and the brain protector is strong - Bugtinib has created a new idea of ALK brain metastasis treatment
Time of Update: 2022-09-07
prefaceBrain metastases have long been the "nightmare" of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). Studies have shown that patients with ALK-positive
-
Change your eating habits and intercept the cancer on the upper body
Time of Update: 2022-09-07
European and American studies on diet, nutrition, lifestyle, health and diseases focus on comparing the effect differences of different food forms, such as vegetables, fruits, fish, vegetable oils, less meat, animal fats, Mediterranean diet practitioners, usually less smoking, more physical activity, less obesity, healthier lifestyle groups, their risk of cardiovascular disease and cancer and the risk of death are significantly reduced.
-
A case report of a case of subcutaneous solitary fibroma of the left foot
Time of Update: 2022-09-07
Case introductionThe patient is a 40-year-old female . Found a painless mass on the left dorsum of the foot for 3 years, and was admitted to the hospital with a feeling of progressive enlargement in t
-
J Clin Oncol: Talimogene Laherparepvec combined with Pemumab for advanced melanoma
Time of Update: 2022-09-07
00343 In a phase Ib study, the combination of Talimogene Laherparepvec (T-VEC) and Pemumab has demonstrated acceptable safety and an encouraging complete response rate (CRR) in patients with advanced melanoma.
-
The whole process record of MDT diagnosis and treatment of colon cancer lung metastasis
Time of Update: 2022-09-07
Department of Imaging: During the follow-up period of the patient, the PET-CT parahilar soft tissue increased glucose metabolism, and combined with the medical history, postoperative recurrence of colorectal cancer with mediastinal lymph node metastasis was considered2.
-
New drugs for tumors, new drugs for tuberculosis, new coronavirus vaccines... New pharmaceutical products at the service trade fair
Time of Update: 2022-09-07
BeiGene: 16 new anti-tumor drugs, all of which have been commercialized"What we are showing this time is 16 anti-tumor drugs that have been commercialized, including 3 independently developed products and 13 authorized introduction products, all of which have been approved for listing in China," the relevant person in charge of BeiGene told the People's Daily health client reporter.
-
Cancer Vaccines: The Next Frontier of Immunotherapy
Time of Update: 2022-09-07
1038/s43018-022-00418-6Figure 1: Types of cancer vaccinesTumor-specific antigens (TSAs) are mainly divided into two broad categories, including new epitopes caused by viral antigens and non-synonymous cell mutations, and two types of tumor-associated antigens (TAA), including tissue-specific antigens and development-specific antigens.
-
JAMA Netw open: Assisted reproductive technology and childhood cancer risk
Time of Update: 2022-09-07
The increased cancer risk associated with ART conception was not due to preterm birth or low birth weight .
The increased cancer risk associated with ART conception was not due to preterm birth or low birth weight .
-
This multiple ground glass nodules, follow-up or surgery?
Time of Update: 2022-09-07
Fig. 7 Lesion 3 in the left upper lobe: light and small ground glass nodules with low density and clear outline, considering the scope of the tumor, the possibility of atypical hyperplasia is high .
-
Do you know? HPV is the source of these cancers
Time of Update: 2022-09-07
In women with a high risk of HPV infection with cervical cells, there are several factors that increase the duration of infection and lead to the chance of cervical precancerous cells: What is HPV (Human Papillomavirus)?HPV is a group of more than 200 types of related viruses, some of which are transmitted through vaginal, anal or oral sex.
-
The whole "case" is to go, the rejuvenation of the | peak circuit, multiple surgeries and polygenic mutation GIST patients meet new hope
Time of Update: 2022-09-07
Clinical diagnosis Small intestinal GIST; High risk; c-KIT Exon11 mutation Treatment progression Adjuvant therapy with postoperative imatinib 400 mg qd.
Clinical diagnosis Small intestinal GIST; High risk; c-KIT Exon11 mutation Treatment progression Adjuvant therapy with postoperative imatinib 400 mg qd.
